PRRT2 and diabetes mellitus: Collectively, these in vitro results point to inappropriately heightened counter-regulatory responses to inflammation as a cause of impaired renal epithelial immunity in diabetes and demonstrate reversal by pharmacological interventions directed at PKC activation and ROS generation.